Lv72
5000 积分 2023-03-02 加入
A phase 1/2 study of donor-derived anti-CD33 CAR T-cell therapy (VCAR33) for relapsed/refractory AML after allogeneic HCT
21天前
已完结
CHIT1-positive microglia drive motor neuron ageing in the primate spinal cord
1个月前
已完结
NKG2D-mediated signaling requires a DAP10-bound Grb2-Vav1 intermediate and phosphatidylinositol-3-kinase in human natural killer cells
1个月前
已完结
Tumor-antigen-independent targeting of solid tumors by armored macrophage-directed anti-TREM2 CAR T cells
1个月前
已完结
CAR T Cells Targeting an Intracellular Leukemia Antigen Promiscuously Presented by Diverse HLA-II Alleles
1个月前
已完结
In vivo genome-wide CRISPR screens in human T cells to enhance T cell therapy for solid tumors
2个月前
已完结
Ultralow-Dose Interleukin 10–Expressing Chimeric Antigen Receptor T Cells in Relapsed/Refractory Diffuse Large B-Cell Lymphoma
2个月前
已完结
Engineered Regulatory T Lymphocytes Promote Infarcted Heart Repair
2个月前
已完结
Engineered Regulatory T Lymphocytes Promote Infarcted Heart Repair
2个月前
已完结
Engineered Regulatory T Lymphocytes Promote Infarcted Heart Repair
2个月前
已完结
皖公网安备34019202002308
